- Home
- / Par Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Par Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$887.5 M
FY, 2011
CreditSafe Score
?
Score changed on Jul 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2013 | FY, 2014 |
|---|---|---|---|
| Revenue | 887.5M | ||
| Cost of goods sold | 539.4M | ||
| Gross profit | 348.1M | ||
| Gross profit margin, % | 39.2% | ||
| General and administrative expense | 173.4M | ||
| Operating expense total | 437.3M | ||
| EBIT | (50.6M) | ||
| EBIT margin, % | -5.7% | ||
| Interest income | 736.0K | ||
| Interest expense | 2.7M | ||
| Pre tax profit | (52.3M) | ||
| Income tax expense | (6.0M) | ||
| Net Income | (26.1M) | (105.9M) |